ZI

Zivo Bioscience IncOOTC ZIVO Stock Report

Last reporting period 30 Jun, 2024

Updated 20 Nov, 2024

Last price

Market cap $B

0.059

Micro

Exchange

OOTC - OTC

ZIVO Stock Analysis

ZI

Uncovered

Zivo Bioscience Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-55/100

Low score

Market cap $B

0.059

Dividend yield

Shares outstanding

9.42 B

Zivo Bioscience, Inc. is a research and development company. The Company operates in both the biotech and agtech sectors, with an intellectual property portfolio comprised of algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques and patented or patent-pending inventions for applications in human and animal health. Its products include Poultry Gut Health, Bovine Mastitis, Canine Joint Health, Human Immune Modification, Algal biomass for human consumption and Biomass for supporting skin health / anti-aging. The Company is also engaged in licensing and selling natural bioactive ingredients derived from their algae cultures to animal, human and dietary supplement and medical food manufacturers. Its product candidates are at different stages of development for different applications.

View Section: Eyestock Rating